• intloko_ibhena_01

Cagrilintide

Inkcazelo emfutshane:

I-Cagrilintide i-synthetic, i-amylin receptor agonist yexesha elide iphuhliswe ukunyangwa kokukhuluphala kunye nokuphazamiseka kwe-metabolic ezinxulumene nobunzima. Ngokulinganisa ihomoni yendalo i-amylin, inceda ukulawula ukutya, ukucotha kwesisu, kunye nokuphucula ukuhlutha. I-API yethu ephezulu ye-Cagrilintide API iveliswa ngokusebenzisa i-chemical synthesis kwaye idibana nemigangatho yemigangatho ye-pharmaceutical-grade, eyenza ifaneleke ukusetyenziswa kwiifom zokulawula ubunzima obuphezulu.


Iinkcukacha zeMveliso

Iithegi zeMveliso

Cagrilintide API

Cagrilintideyinto esebenza ixesha elide, eyenziwe ngamachizai-amylin receptor agonist, iphuhliswe njengonyango lwenoveliukutyeba kunye nobunzima obunxulumene nokuphazamiseka kwemetabolism. Yenzelwe ukulinganisa iziphumo zeamylin yomntu, ihomoni edityaniswe ne-insulin yi-pancreatic β-cell, edlala indima ebalulekileyo ekulawuleni ukutya, ukukhupha isisu kunye nokuhlutha.

ICagrilintide iphuhliswa njengeKanye ngeveki unyango olutofwayo, enikezela ngesisombululo esithembisayo kakhuluulawulo lobunzima obungapheliyo, ngakumbi xa isetyenziswa kwiukudibanisa ne-GLP-1 i-receptor agonistsnjengeSemaglutide.


Indlela yokwenza

I-Cagrilintide yenza iziphumo zayo zonyango ngokuzibophelela kunye nokusebenzai-amylin receptors, ikhokhelela kwi:

  • Ukucinezelwa kokutya

  • Ukulibaziseka kokukhupha isisu, eyandisa imvakalelo yokuhlutha

  • Ukunciphisa ikhalori kunye nokunyuka kwe-satiety

Lo mmiselo we-multimodal wokuthathwa kokutya kwenza kube ngumgqatswa ofanelekileyo wokulawulaukutyeba kakhulu kunye neengozi ezinxulumene ne-cardiometabolic.


Uphando kunye neeNkcukacha zeKlinikhi

I-Cagrilintide ibonise iziphumo ezithembisayo kwiimvavanyo ezininzi zeklinikhi, kuqukaIzifundo zeSigaba se-2 eziqhutywe nguNovo Nordisk:

  • Xa isetyenziswayedwa, iCagrilintide ikhokelela kwiukuncipha kobunzima obuxhomekeke kwidosi, kunye ukuyaI-10.8% yokunciphisa umzimbangaphezu kweeveki ezingama-26 kubantu abatyebe kakhulu.

  • Niniidibene neSemaglutide, umphumo wokulahlekelwa kwesisindo uphuculwe kakhulu-ukuphumelelaukunciphisa okukhulu kubunzima bomzimba kune-arhente yodwa.

  • Ibonisileukunyamezela okulungileyokwayeiprofayili yokhuseleko oluzinzileyo, kunye neziganeko ezimbi kakhulu iimpawu zesisu esiswini.

Le ndlela yokudibanisa yinxalenye ephambili yeumbhobho weyeza lokulwa ukutyeba kwisizukulwana esilandelayo, kujoliswe kwiindlela ezininzi zokuhlutha (i-amylin + GLP-1).


Umgangatho we-API kunye nokuVeliswa

YethuCagrilintide API:

  • Iveliswa ngokuphambilii-soli-phase peptide synthesis (SPPS)ngokucoceka okuphezulu kunye nokuzinza kweekhemikhali

  • Yenzelweuphuhliso lokwenziwa kweetofu

  • Udibana namazwe ngamazweimigangatho yamayeza (ICH, GMP, FDA)

  • Iyafumaneka kwiulinge kwimveliso yorhwebo, ilungele ukusetyenziswa kweklinikhi kunye nezoshishino


Amandla oNyango

ICagrilintide imele aindlela entshakulawulo lobunzima ngaphaya kwe-GLP-1 monotherapy. Iprofayile yentshukumo ehambelanayo iyenza ilungele:

  • Ukutyeba kakhulu kunye nezigulana ezityebileyo(neswekile okanye ngaphandle kwayo)

  • Unyango oludibeneyoukwenzela ukunciphisa umzimba

  • Uphuhliso lwexesha elizayo kwiisifo se-metabolic kunye ne-prediabetes


  • Ngaphambili:
  • Okulandelayo:

  • Bhala umyalezo wakho apha kwaye uwuthumele kuthi